With a rapid response from manufacturers, we could deliver a point-of-care test kit to support mass-scale testing within the NHS and globally."
Similar death rates have been experienced in China earlier this year (3,339) and are rising globally with particularly high death rates in the US (18,761 with over half of deaths in New York State), Italy (18,939), Spain (16,353) and France (13,197).As the Coronavirus disease 2019 (Covid-19) pandemic takes hold, nurses are on the front line of health and social care in the most extreme of circumstances. The researchers believe that the device would be operated by ambulatory care professionals, nurses, and biomedical scientists. It would also let people self-isolating test themselves and health care workers test patients to help slow the spread of the pandemic and ease the burden on the NHS.“Now we have access to multiple genomes (blueprint) of SARS-CoV-2 virus, we can develop reliable molecular assay in a week and have them up and running on the device in three or four weeks,” said Brunel University London’s Professor Wamadeva Balachandran. At the time of writing (11th April 2020) there are 1.72 million Covid‐19 infections and 104,889 deaths worldwide. Everyone is crying out for these tests, and many will take a long time. In the UK the first recorded death was on the 5th of March 2020 and in just 37 days 9,875 deaths in hospital have been recorded. By accepting you agree to cookies being stored on your device. Once infection is identified, the intelligent system will track down all people who had close contact with the newly identified patient in the last 14 days, alert them about the threat of having CoVID-19 and advise them what to do via the mobile phone app. Despite this, the RCN (Royal College of Nursing in the UK) has reported that nurses feel “repeatedly” ignored by their employers when they raise concerns about their mental health (Mitchell 2019). A focus on personal responsibility for psychological health and well-being and an over-emphasis on nurses being ‘resilient’ in the face of under-staffing and often intense emotional work is consistently challenged by nurses and nurse academics (Traynor 2018). The 10th of April saw the highest number of UK daily deaths (980) to date. We stress the importance of peer and team support to enable positive recovery after acutely stressful and emotionally draining experiences, and outline what managers, organisations and leaders can do to support nurses at this most critical of times. And cases will rise over the next few months. Treating resilience as an individual trait is seen to ‘let organisations off the hook’ (Traynor 2018); yet has often been the focus of organisational strategies to date. The team has adapted it to detect CoVID-19 in humans and is talking with backers to get it urgently mass-produced.The current system is capable to perform diagnostics at any location with very minimal training.
With local hospitals’ help we aim to do a limited number of tests with available positive and negative samples.” The idea is to try and make it cheaper than other tests so it can be used worldwide at home, in GP surgeries, hospitals and workplaces.
“The team firmly believe that both identifying CoVID-19 infection and minimising the spread of infection are important. “Normally, anything like this would have to go through clinical trials,” said Professor Balachandran. Professor Roberto La Ragione, Deputy Head of the School of Veterinary Medicine at the University of Surrey, said: “We are delighted to be involved in the development of rapid diagnostic tools for CoVID-19. Once infection is identified using this device, the app will automatically update the database and the intelligent system will track down all individuals who have been in close contact with the newly identified patient, alert them about the threat of having CoVID-19 and make recommendations regard further steps”, said Dr Anil Fernando, University of Surrey.© Centers for Disease Control and Prevention (CDC)/Alissa Eckert, MS; Dan Higgins, MAMS Professor Roberto La Ragione, Deputy Head of the School of Veterinary Medicine at the University of Surrey, said: “We are delighted to be involved in the development of rapid diagnostic tools for CoVID-19. According to the Imperial College model, this pandemic might last for 18 months.
At the time of writing (11th April 2020) there are 1.72 million Covid‐19 infections and 104,889 deaths worldwide.
We reflect during a moment in time (week three of lockdown in the UK and week 5/6 across Europe) to highlight the issues facing nurses at this unprecedented time.At the bedside 24 hours a day seven days a week, in similar outbreaks, nurses have had the highest levels of occupational stress and resulting distress compared to other groups (Cheong and Lee, 2004, Maunder et al., 2006, Nickell et al., 2004). The 10th of April saw the highest number of UK daily deaths (980) to date. An international team of researchers, led by Professor Margaret Rayman at the University of Surrey, has identified a link between the COVID-19 cure rate and regional selenium status in China.
This does not work at the best of times and certainly is not appropriate now in these most difficult of circumstances. It will have a huge impact on the population at large.” “The team strongly believes that with our combined expertise, we will be able to make this device and its associated system available for adoption within a few weeks and take a step closer to beating Covid-19,” said Molecular Virologist The team is also working on adding a tele-medicine functionality to the mobile app which can control the device, track the user’s movement with government permission and contact anyone who has had a close interaction with the person diagnosed to suggest the next steps to do, in order to reduce the CoVID-19 infection and spread to others. “But this is not a normal situation.